Literature DB >> 35349657

Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682.

Adem Y Dawed1, Sook Wah Yee2, Kaixin Zhou1, Nienke van Leeuwen3, Yanfei Zhang4, Moneeza K Siddiqui1, Amy Etheridge5, Federico Innocenti5, Fei Xu6, Josephine H Li7,8, Joline W Beulens9, Amber A van der Heijden10,11, Roderick C Slieker3,10, Yu-Chuan Chang2, Josep M Mercader7,8, Varinderpal Kaur7,8, John S Witte12, Ming Ta Michael Lee4, Yoichiro Kamatani13, Yukihide Momozawa13, Michiaki Kubo13, Colin N A Palmer1, Jose C Florez7,8,14, Monique M Hedderson12, Leen M 't Hart3,15,16, Kathleen M Giacomini2,17, Ewan R Pearson1.   

Abstract

Entities:  

Year:  2022        PMID: 35349657      PMCID: PMC9016729          DOI: 10.2337/dci21-0066

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


× No keyword cloud information.
  7 in total

1.  Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1.

Authors:  E van de Steeg; R Greupink; M Schreurs; I H G Nooijen; K C M Verhoeckx; R Hanemaaijer; D Ripken; M Monshouwer; M L H Vlaming; J DeGroot; M Verwei; F G M Russel; M T Huisman; H M Wortelboer
Journal:  Drug Metab Dispos       Date:  2012-12-17       Impact factor: 3.922

2.  Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.

Authors:  H X Zheng; Y Huang; L A Frassetto; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  2008-10-08       Impact factor: 6.875

Review 3.  Defining drug response for stratified medicine.

Authors:  Mike Lonergan; Stephen J Senn; Christine McNamee; Ann K Daly; Robert Sutton; Andrew Hattersley; Ewan Pearson; Munir Pirmohamed
Journal:  Drug Discov Today       Date:  2016-11-03       Impact factor: 7.851

4.  Comment on Dawed et al. Genome-Wide Meta-Analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682.

Authors:  Ke Wang; Mai Shi; Aimin Yang; Brian Tomlinson; Juliana C N Chan; Elaine Chow
Journal:  Diabetes Care       Date:  2022-04-01       Impact factor: 17.152

5.  CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes.

Authors:  Ke Wang; Aimin Yang; Mai Shi; Claudia C H Tam; Eric S H Lau; Baoqi Fan; Cadmon K P Lim; Heung Man Lee; Alice P S Kong; Andrea O Y Luk; Brian Tomlinson; Ronald C W Ma; Juliana C N Chan; Elaine Chow
Journal:  Clin Pharmacol Ther       Date:  2021-10-30       Impact factor: 6.903

6.  CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide.

Authors:  Fayou Yang; Xiaomin Xiong; Yonghua Liu; Hong Zhang; Shibo Huang; Yuqing Xiong; Xiao Hu; Chunhua Xia
Journal:  Sci Rep       Date:  2018-07-20       Impact factor: 4.379

7.  Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.

Authors:  Adem Y Dawed; Sook Wah Yee; Kaixin Zhou; Nienke van Leeuwen; Yanfei Zhang; Moneeza K Siddiqui; Amy Etheridge; Federico Innocenti; Fei Xu; Josephine H Li; Joline W Beulens; Amber A van der Heijden; Roderick C Slieker; Yu-Chuan Chang; Josep M Mercader; Varinderpal Kaur; John S Witte; Ming Ta Michael Lee; Yoichiro Kamatani; Yukihide Momozawa; Michiaki Kubo; Colin N A Palmer; Jose C Florez; Monique M Hedderson; Leen M 't Hart; Kathleen M Giacomini; Ewan R Pearson
Journal:  Diabetes Care       Date:  2021-10-04       Impact factor: 17.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.